Brendan B. Springstubb

CIK: 0001687656

Transaction Breakdown

Open Market Buys (P)3 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

EVH

Evolent Health, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

EVH
Evolent Health, Inc.
Jun 4, 2026
Award(A)
Direct
41.1K shares-
EVH
Evolent Health, Inc.
Nov 18, 2025
Purchase(P)
Direct
10K shares at avg. $3.82$38K
EVH
Evolent Health, Inc.
Jun 5, 2025
Award(A)
Direct
22K shares-
EVH
Evolent Health, Inc.
Mar 7, 2025
Purchase(P)
Direct
15K shares at avg. $9.27$139K
EVH
Evolent Health, Inc.
Mar 4, 2025
Purchase(P)
Direct
5K shares at avg. $8.75$44K
EVH
Evolent Health, Inc.
Mar 3, 2025
Award(A)
Direct
6.8K shares-

		Type	Shares	Price		Ownership
Jun 4, 2026	EVH Evolent Health, Inc.	Award(A)	41,096	-	$0	Direct
Nov 18, 2025	EVH Evolent Health, Inc.	Purchase(P)	10,000	$3.82	$38,199	Direct
Jun 5, 2025	EVH Evolent Health, Inc.	Award(A)	21,979	-	-	Direct
Mar 7, 2025	EVH Evolent Health, Inc.	Purchase(P)	15,000	$9.27	$139,050	Direct
Mar 4, 2025	EVH Evolent Health, Inc.	Purchase(P)	5,000	$8.75	$43,750	Direct
Mar 3, 2025	EVH Evolent Health, Inc.	Award(A)	6,842	-	-	Direct

1-6 of 6 transactions

About Springstubb Brendan B

Springstubb Brendan B (SEC CIK 0001687656) files insider reports with the SEC as Director of Evolent Health, Inc. (EVH).

Signal8 holds 6 ownership filings by Springstubb Brendan B (1 Form 3, 5 Form 4), filed between Feb 14, 2025 and Jun 8, 2026. Those filings report 6 transactions, from Mar 3, 2025 to Jun 4, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Springstubb Brendan B's filings is in ARLINGTON, VA.

Recent filings by Springstubb Brendan B

Jun 4, 2026: Grant or award of EVH shares (Form 4, code A).
Nov 18, 2025: Open-market purchase of EVH shares (Form 4, code P).
Jun 5, 2025: Grant or award of EVH shares (Form 4, code A).
Mar 7, 2025: Open-market purchase of EVH shares (Form 4, code P).
Mar 4, 2025: Open-market purchase of EVH shares (Form 4, code P).

Other insiders filing for Evolent Health, Inc. (EVH)

McCarthy Daniel Joseph, PRESIDENT
Blackley Seth, Chief Executive Officer
Weinberg Jonathan, General Counsel
Shams Aammaad, Chief Accounting Officer
Ajayi Toyin, Director
Glass Russell Monroe, Director

How to read Form 4 transaction codes